Company / SG&A per Share
PTC Therapeutics, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$4.47
FY2025
5-year range
$2.91 / $4.55
FY2021-FY2025
Trend
+12.4%
vs FY2024
Sector context
#37 of 210
Health Care
What the data says
PTC Therapeutics, Inc.'s sg&a per share of $4.47 is higher than 82% of companies in the Health Care sector (FY2025). SG&A per Share has fluctuated over the past 10 years, ranging from $2.48 in FY2020 to $4.55 in FY2023.
Based on SEC 10-K filings.
4.47 in FY2025 with a 5-year CAGR of +12.5%. Top quartile in the Health Care sector.
Remained stable around $4.47 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +8.9%
- 5-Year CAGR
- +12.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 210This company $4.47 Sector average $29.50
▼
-84.9% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 12.4% year-over-year.
- Ranks #37 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2023.
- Lowest sg&a per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.47 | +12.4% |
| FY2024 | $3.97 | -12.6% |
| FY2023 | $4.55 | +31.4% |
| FY2022 | $3.46 | +19.1% |
| FY2021 | $2.91 | +17.2% |
| FY2020 | $2.48 | -28.0% |
| FY2019 | $3.44 | -6.8% |
| FY2018 | $3.69 | +4.0% |
| FY2017 | $3.55 | +23.9% |
| FY2016 | $2.86 | +14.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026